Chlamydia Rapid Test

We made a comprehensive literature search that included the Cochrane Register of Diagnostic Test Accuracy Studies; the Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library), MEDLINE (through PubMed), and EMBASE (last search 6 January 2011). Selected journals likely to contain relevant papers were handsearched from 1992 to 2010 (December). We also searched CERVIX, the bibliographic database of the Unit of Cancer Epidemiology at the Scientific Institute of Public Health (Brussels, Belgium) which contains more than 20,000 references on cervical cancer.More recent searches, up to December 2012, targeted reports on the accuracy of triage of ASCUS or LSIL with other HPV DNA assays, or HPV RNA assays and other molecular markers. These searches will be used for new Cochrane reviews as well as for updates of the current review.

HPV is so common in the United States that nearly all men and women will contract the virus at some point during life (Center for Disease Control and Prevention [CDC], 2017). In the United States, in 2008, it is reported that 3.2 million, or one in four adolescent women, ages 14 to 19 have had or have an STD (Kostas-Polston et al., 2012). The rate of HPV cases has only increased since 2008. The prevalence of a genital infection with any HPV type was 42.5% among United States during 2013–2014 (CDC, 2017). The incidence of HPV in the United States is about 14 million people each year.

BARBARA, A. MAJERONI, A. And SREELATHA-UKKADAM, M. (2007) Screening and Treatment for Sexually Transmitted Inf

Chlamydia is a sexual transmitted disease (STD) caused by the bacterium Chlamydia trachomatis, which is passed during sexual contact. Chlamydia is the most reported STD in the United States. Chlamydia affects males and females, but females have higher rates of contracting chlamydia. Rates of reported cases of chlamydia in the united states in 2014 in adolescent’s males age 15-19 were

Sexually transmitted infections are a very current, modern day health care issue. These infections are passed during unprotected genital, anal or oral sex. There are sometimes symptoms of the various infections however there are some infections that can also be symptom free and therefore can go undetected for quite some time. Young people in the UK typically aged 15-24 have the highest rates of sexually transmitted infections. There is a link between this age group and those living in socioeconomically deprived areas, suggesting these particular regions need better and easier access to healthcare services in order to detect, treat and avoid further spreading and damage caused by the infections. Raising awareness of the causes of each infection and symptoms is vital. The most common types of infections are: Chlamydia, Genital herpes and warts, gonorrhea,

Over one million cases of Chlamydia were reported to the CDC in 2013. Despite this large number of reports it actually was a decrease by 1.5% since 2012 (CDC, 2014). Epidemiology statistics showed an increase in reported syphilis, including congenital. Other sexually transmitted diseases can pose higher risks for acquiring HIV. According to new studies, HIV is growing faster in populations that are over 50 versus 40 years and younger (BenRose, 2014). Factors may play a role in this such as higher divorce rates, new medications, and safe sex measures. Therefore, it is important for the healthcare provider screen for sexual activity and any change in sexual partners to provide routine testing when necessary and education on preventive

Nationwide free STD testing centers are convenient locations that test for a large number of conditions, so no one will know what you are there for. They are abided and instructed by the HIPAA Privacy Rule, so your medical information stays safe. They also safeguard your data with secure industry-standard encryption. Your STD testing process is guaranteed to be private, secure and reliable.

Chlamydia denotes an extensive spectrum of causal determinants, which must be evaluated and understood in order to identify why distribution is variant across assorted subpopulations. Whilst transmission is largely the result of either an absence of suitable sexual health awareness or social stigma surrounding the disease, determinants can still be separated into several categories.

STDs place a significant economic strain on the U.S. healthcare system. According to CDC conservatively estimates, the lifetime cost of treating eight of the most common STDs contracted in just one year is $15.6 billion (2013). Each year, more than “$1 billion in direct and indirect costs are expended on Chlamydia infections in the United States. Many of these costs result from the management of women with PID and its complications” (Thompson, n.d.). Further growth in the economic burden of chlamydial infections will occur as these infections become more prevalent. Although chlamydia screening is expanding, many women who are at risk are still not being tested, thus,

The possibility of sexually transmitted diseases and infections poses a huge risk to all those who are sexually active. Without proper diagnosis and treatment, STDs and STIs such as Chlamydia, Gonorrhea, HIV/Aids, and HPV may leave permanent damage to one’s body and increase the likeliness of cervical cancer, infertility, ectopic pregnancy, and more. Planned Parenthood offers extensive testing for patients upon every visit to decrease the spread and damage of any and all diseases. According to Sonfield’s research, “Nearly half of female family planning clients receive chlamydia and gonorrhea tests, and 19% receive an HIV test… Without access to these services, in 2010, an estimated 3.6 million women and men would have forgone chlamydia or gonorrhea testing, which would have resulted in tens of thousands of undetected and untreated STIs. By reducing transmission to partners, these testing services helped prevent an estimated 99,000 chlamydia infections, 16,000 gonorrhea infections and 410 HIV infections that year” (Sonfield). The great amount of transferable diseases requires the counteractive services of Planned Parenthood to provide treatment and prevent the further spread of disease. Patients are offered and encouraged to receive testing to maintain sexual health. In the event of an issue, full treatment options are presented at low or no cost and

In the attempt to avoid complications and further accuracy of diagnosis, more modern tests have been created. The Roche Amplicor PCR, polymerase chain reaction, was the first diagnostic test using nucleic acid amplification. This type of test “involves rapid thermal cycling in a specially programmed thermal cycler.” Test samples usually consist of urethral swabs for both men and women and cervical swabs for women. The second nucleic acid amplification test was the Abbott LCx test. Instead of PCR, Abbot LCx uses LCR, ligase chain reaction, to test for diagnosis. Results from this particular test may contain a more accurate realization for the chlamydial bacteria because it is species specific. Both nucleic acid tests concentrate on finding certain mutations in the target DNA.

“Silent “ infection is what chlamydia is known for because most people who get infected show no signs or evidence and can fall short of the physical examination findings when it comes to the disease. Halberstaedter and Von Prowazek first discovered chlamydia in 1907. These two came together that led to the discovery of chlamydial disease, which was observed in the mucus membrane of the front eye of an infected orangutan. However, over the last hundreds years with all the up coming studies about chlamydia we are able to

Again, because chlamydia is often asymptomatic, screening is usually the only means to obtaining a confirmed diagnosis and initiating treatment. So the question is, how do we encourage testing for patients who are not experiencing symptoms?

This study was limited due to the small sample size. Although the conclusions are valid, more research with a

Three separate randomized controlled trials for cervical screening have been conducted among Indian women of the